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Purified xenogeneic cartilage matrix components, including proteoglycan subunits, chon-
droitin 4 sulfate, and chondroitin 6 sulfate, were inoculated into the kneejoint of rabbits, and
local as well as systemic responses were evaluated. Proteoglycan was associated with synovial
hyperplasia and infiltrates of eosinophils and lymphocytes and with rising titers of anti-
proteoglycan antibodies in a tanned sheep rbc hemagglutination assay over a six-week period
of weekly intra-articular injections and observations. Chondroitin sulfates failed to evoke
detectable changes in thejoint or serum. Immunogenicity ofcartilage matrix components may
play a role in allogeneic and xenogeneic osteochondral grafts, and it is also possible that
autogenous matrix immunogens exist and contribute to progression of degenerative joint
disease. The immunogenicity of allogeneic and autogenous cartilage matrix components re-
mains undefined.
The histologic features and metabolic state of osteoarthritic articular cartilage
have been described in detail [1-4], but the etiology and pathophysiology of most
degenerative joint disease remain unknown. Initially, trauma was felt to be the
primary cause and, indeed, many animal models of osteoarthritis are based upon
this concept [5,6]. Chrisman [7] has presented evidence that biochemical insults,
particularly catabolic enzyme activity, also play a dominant role in the advancement
of degenerative process. More recently, there is support for the addition of im-
munologic factors that, along with mechanical and biochemical events, comprise a
vicious cycle responsible for progression of the osteoarthritic lesion. It is the ex-
istence and potential role of matrix immunogens that is the subject of this report.
Hulten and Gellerstedt [8] demonstrated that homogenates of articular cartilage
were capable ofproducing a synovitis, presumably based upon a chemically induced
inflammatory reaction. They reported in 1940 that intra-articular injections ofeither
autologous or allogeneic hyaline cartilage, crude in preparation by today's stan-
dards, caused a synovitis in the rabbit. No changes, however, were observed in the
cartilage by light microscopic evaluation of hematoxylin- and eosin-stained sections
following the infrequent dosage schedule of once or twice a month for half a year.
Lloyd-Roberts [9] noted fragments ofbone and cartilage phagocytized by synovium
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in arthritic human hips and postulated the synovial inflammation and capsular
fibrosis that accompanies degenerative joint disease was a result of this debris.
Chrisman, Fessel, and Southwick [10] addressed the same hypothesis by injecting
homogenates of autologous costal cartilage into canine kneejoints on a weekly basis
for one to 12 months. Some animals followed for six months or longer developed
marginal osteophytes and subchondral cyst formation in addition to chronic
synovitis. In order to define the relative contributions of the various matrix com-
ponents to this joint reaction, George and Chrisman [11] separately injected purified
autologous collagen, proteoglycan, purified chondroitin sulfate A (derived from
calf nasal cartilage), or chondroitin sulfate C (derived from shark) into the knee
joints of rabbits for 10 to 15 weeks prior to sacrifice and evaluation. Synovitis,
characterized by hypertrophy of the lining cell layer and a cellular infiltrate, was
seen most strikingly after proteoglycan treatment, followed in severity by chon-
droitin sulfate C, and, to a lesser degree by chondroitin sulfate A, with no reaction
attributed to the collagen preparation. Parenthetically, it was not known at that time
that skin collagen (type I), the source used in this experiment and which failed to
cause a reaction, differed from cartilage collagen (type II). It is now recognized that
type II collagen of cartilage origin under proper circumstances is, indeed, antigenic
[12]. The authors speculated that the synovitis and arthritis represented a chronic
chemical inflammation resulting from excessive concentrations of the polysac-
charide fraction of cartilage debris. Thus, the traditional role of mechanical injury
in osteoarthritis was revised to include chemically mediated events. The protection
offered by salicylates as noted by Simmons and Chrisman [13] supported this view.
More recently it has been speculated that cartilage matrix components [14], chon-
drocytes [15,16] or both may evoke specific immune responses that also play a role
in the pathophysiology of degenerative joint disease, particularly if these potential
sources of immunogens were sequestered from the host under normal cir-
cumstances. This concept ofcartilage behaving as an immunologically privileged site
with normally hidden immunogens has potential relevance to our understanding of
inflammatory arthritis, articular cartilage transplantation, and chondrogenic
malignancies.
The present study was undertaken to evaluate the immunogenicity of matrix com-
ponents in axenogeneic circumstance. In particular, we chose to assess the ability of
purified bovine nasal proteoglycan and chondroitin sulfate A and chondroitin
sulfate C of shark origin to evoke a systemic humoral response in rabbits following
intra-articular inoculation.
MATERIALS AND METHODS
Groups of four to six mature New Zealand white rabbits received weekly intra-
articular injections of the knee for six weeks with 4 mg of either proteoglycan
subunit (fraction AID of bovine nasal cartilage), chondroitin sulfate A (bovine nasal
cartilage), chondroitin sulfate C (shark), or saline as a control. Sera were collected
prior to initiation ofthe immunization schedule and weekly thereafter until sacrifice
one week after the sixth injection. Synovial tissue was removed from the treated
knees for histologic evaluation, and paraffin-embedded tissues were sectioned and
stained with hematoxylin and eosin.
Sera were stored frozen at -20°C until evaluated with a standard passive tanned
sheep red blood cell microhemagglutination assay [17]. The same matrix com-
ponents used for inoculation served as antigens in the assay, and sera were absorbed
against sheep red blood cells and bovine serum albumin prior to evaluation.
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FIG. 1. Synovium from
rabbits receiving intra-
articular saline as a control
was histologically normal.
RESULTS
Histology
No abnormalities were noted in synovial tissue removed from rabbit knees in-
jected with either chondroitin sulfates A or C. Proteoglycan, on the other hand, was
associated with a significant inflammatory response in all four rabbits evaluated
after the six-week period of treatment. This tissue response was characterized by
synovial thickening and cellular infiltrates, including eosinophils and lymphocyte
clusters (Figs. 1 and 2).
Humoral Antibody
Chondroitin sulfates A and C failed to evoke a detectable response in this model,
but proteoglycan caused rising titers of hemagglutinating antibodies in all four rab-
bits (Fig. 3).
DISCUSSION
Proteoglycan subunits ofbovine nasal cartilage origin caused a local synovitis and
appearance of systemic hemagglutinating antibodies following six weekly intra-
articular injections of this purified matrix component in rabbits. Xenogeneic chon-
FIG. 2. Synovium from rabbits
receiving intra-articular xenogeneic
proteoglycan was characterized by
thickening and infiltration of eosin-
ophils and lymphocytes.
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1:10 FIG. 3. Rising titers of anti-proteoglycan
antibody were identified in all four animals
evaluated over six weeks by a microhemag-
1 2 3 4 5 6 wks glutination assay.
droitin sulfates A and C failed to cause a detectable joint reaction (by gross and
histologic examination) or immune response in this same model.
Previous studies of cartilage immunogenicity inspired by its significance as a
transplantable tissue have, for the most part, focused attention on cell-surface
transplantation antigens. Elves [15] has demonstrated that sheep chondrocytes
possess histocompatibility antigens identical to those found on the host's peripheral
lymphocytes. He further speculated that residual matrix on cartilage cells following
isolation procedures may mask these antigenic sites. Langer and Gross [16] de-
scribed the ability of syngeneic rat chondocytes to evoke a positive response in a
leukocyte migration inhibition assay, suggesting sequestered chondrocytes were
capable of causing autoimmune responses. Similarly, they demonstrated that intact
articular cartilage transferred between disparate strains of inbred rats were not im-
munogenic, again using leukocyte migration inhibition as an indicator, but slices of
articular cartilage or isolated chondrocytes did cause a positive response. The
presence of humoral antibody was evaluated with a chromium-release assay and
gave similar patterns of reactivity. The implication of these data was that cartilage
matrix imposes both an afferent and efferent block to the immune response,
preventing antigen from being recognized and not allowing antibodies, if formed, to
reach chondrocytes within the matrix. This is consistent with the theoretical "pore"
size of articular cartilage described by Maroudas and associates [18].
More recently, Yablon and co-workers [19,20] have demonstrated the ability of
matrix components to act as potential immunogens in a canine distal femoral
osteochondral allograft transplantation model. Rabbit anti-dog proteoglycan and
link protein were used in direct immunofluorescent tests to demonstrate these matrix
components in synovial tissue six weeks after transplantation of articular surfaces,
and revealed the presence of immune complexes in these tissues by 12 weeks follow-
ing the surgical procedure. Skin tests and lymphocyte migration inhibition assays
became positive by the twenty-sixth week of observation reflecting the presence of
cell-mediated responses, and circulating humoral antibody to proteoglycan and link
protein was detected by radioimmunoassay at this same point in time. These im-
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munologic findings coincided with abnormal histologic features in the synovium at
26 weeks (primarly hypercellularity) and the appearance of pannus and cartilage
degeneration.
There has recently been interest in evaluating the matrix components of malignant
cartilage tumors. Rosenberg and colleagues [21,22] have demonstrated abnor-
malities in keratan sulfate content and chain length of proteoglycans isolated from
human chondrosarcomas. Mankin and co-workers [23] have also identified
qualitative and quantitative changes in proteoglycan from chondrosarcomas, in-
cluding the presence of an uncharacterized "excess protein" in these tumors. These
biochemical alterations may serve diagnostic or prognostic roles in the future.
The majority of attention to the immunogenicity of matrix components has been
prompted by interest in animal models of arthritis. The original observations of
Chrisman, Fessel, and Southwick [10] and George and Chrisman [11] have already
been mentioned. Also, as previously stated, typeII collagen has been demonstrated
to be immunogenic under proper circumstances and the detection of anticollagen an-
tibodies in various disease states, including arthritis, has been exemplified by the
work of Trentham [12]. Poole et al. [24] described rheumatoid-like changes in knee
joints ofapproximtely 50 percent of rabbits with serum sickness induced with bovine
serum albumin. The histologic description of synovial lining cell hyperplasia and
lymphocyte accumulations, in the presence of immune complexes, is essentially the
same as described by Chrisman [10,11] in his previous work.
Poole, Rosenberg, and co-workers [25,26] presented data supporting the im-
munogenicity of purified xenogeneic proteoglycan subunits and link protein follow-
ing systemic challenge, the two components being immunologically distinct, and the
lack of cross-reactivity between bovine proteoglycan and human proteoglycan
subunits was also demonstrated. Similar conclusions were reported by Wieslander
and Heinegard [27], again using purified bovine proteoglycan and link protein in a
rabbit model and evaluating the response with rocket and crossed immunoelec-
trophoresis. Glant and co-workers [28] evaluated collagen-free cartilage extracts
which they characterized as proteoglycan with some glycoprotein contamination,
obtained from bovine, porcine, and human cartilage and injected into the foot pad
as well as intramuscularly into rabbits. Using a tanned sheep red blood cell hemag-
glutination assay, they found humoral antibodies as early as nine days following in-
oculation with rising titers thereafter. Immunodiffusion assays became positive after
approximately six weeks, revealing at least two separate species of proteoglycan.
Skin tests were positive after the first week and an additional indicator of cell-
mediated immunity, lymphocyte migration inhibition, was also positive shortly after
exposure to these antigens. Glant et al. [28] suggested that the core protein of pro-
teoglycan (along with glycoprotein) accounted for the immunogenicity of hyaline
cartilage and further stated that glycosaminoglycans were not only devoid of im-
munogeneic properties but were also capable of masking antigenic sites of other
matrix subunits.
While not strictly an arthritic disorder, Marshall et al. [29] have described the con-
cept of "chemical radiculitis" that they postulate occurs when glycoprotein is
liberated from nuclear material of intervertebral discs through a ruptured annulus
and gains access to nerve roots. They used an indirect immunofluorescent test in
which the patient's serum was reacted with fluorescenated nuclear proteins and then
layered over tissue sections of nucleus pulposis. Increasing titers were found in some
patients after the third week of symptoms.
In summary, our current study in a small group of animals demonstrates both a
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local and systemic response to intra-articular xenogeneic purified proteoglycan
subunits. With the exception of the study by Yablon, all previously reported in-
vestigations regarding the immunogenicity of matrix components were also carried
out in xenogeneic systems, and none of these past reports evaluated an intra-articu-
lar route ofimmunization followed by assessment of systemic responses. This study
serves to re-emphasize that cartilage matrix components appear to be an important
additional source of immunogenicity that may be of significance in osteochondral
allograft recipients. A pathogenic role may also exist in arthritis, as may a diag-
nostic and/or prognostic function in cartilage tumor-bearing patients. The im-
munogenicity of allogeneic matrix components must now be explored, and the
possibility of autoimmunization cannot be dismissed without further investigation.
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